Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies

Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial

(2011) John A. Bosso et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin: We Can't Get There From Here

(2011) N. Patel et al.   CLINICAL INFECTIOUS DISEASES

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

(2010) E. Rubinstein et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy

(2010) Annie Wong-Beringer et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists

(2009) Michael J. Rybak et al.   CLINICAL INFECTIOUS DISEASES

Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients

(2009) Thomas P. Lodise et al.   CLINICAL INFECTIOUS DISEASES

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections

(2009) Elizabeth D Hermsen et al.   Expert Opinion On Drug Safety